Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-039259
Filing Date
2022-06-24
Accepted
2022-06-24 16:32:58
Documents
2
Period of Report
2022-06-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4093
2 POA DOCUMENT poa.txt EX-24 4436
  Complete submission text file 0001209191-22-039259.txt   9944
Mailing Address 2755 CAMPUS DRIVE, SUITE 240 SAN MATEO CA 94403-2538
Business Address
MOMTAZEE JAMES C (Reporting) CIK: 0001209181 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38959 | Film No.: 221040556

Mailing Address 421 KIPLING STREET PALO ALTO CA 94301
Business Address 421 KIPLING STREET PALO ALTO CA 94301 (650) 391-9740
BridgeBio Pharma, Inc. (Issuer) CIK: 0001743881 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations